Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 225662

Immunocompetence in Non-seminomatosus Testicular Cancer Patients Before any Treatment and One Year After Completion of Therapy


Kaštelan, Željko; Pasini, Josip; Derežić, Danijel; Lukač, Josip; Kusić, Zvonko; Mrazovac, Danijel; Šošić, Hrvoje; Kaštelan, Maja
Immunocompetence in Non-seminomatosus Testicular Cancer Patients Before any Treatment and One Year After Completion of Therapy // Anticancer Research, 24 (2004), 5B; 3251-3255 (podatak o recenziji nije dostupan, članak, ostalo)


CROSBI ID: 225662 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Immunocompetence in Non-seminomatosus Testicular Cancer Patients Before any Treatment and One Year After Completion of Therapy

Autori
Kaštelan, Željko ; Pasini, Josip ; Derežić, Danijel ; Lukač, Josip ; Kusić, Zvonko ; Mrazovac, Danijel ; Šošić, Hrvoje ; Kaštelan, Maja

Izvornik
Anticancer Research (0250-7005) 24 (2004), 5B; 3251-3255

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo

Ključne riječi
Non-seminomatous testicular cancer; immunocompetence

Sažetak
Assessment of immunocompetence in non-seminomatous testicular cancer (NSTC) patients. Materials and Methods: In the peripheral blood of 43 patients with NSTC, lymphocyte subsets, lymphocyte reactivity to mitogens, NK cell activity as well as neutrophil and monocyte phagocytic functions were studied. Results: The proportion and number of T- and B- lymphocytes, lymphocyte reactivity to mitogens as well as neutrophil and monocyte phagocytic functions were equal in patients with localized disease and in those with metastatic disease and they not differ from those in controls. The NK cell number and NK cell activity, however, were significantly impaired in both patient groups. The patients with metastatic disease had a lower NK cell activity than those with localized disease. One year after the completion of anticancer treatment, the NK cell number and cytotoxic activity recovered in both groups of patients. Conclusion: These results suggest that patients with NSTC are primarily deficient in NK cell number and their cytotoxic function influence the host's ability to control the proliferation and spread of tumor cells

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
0134001
0134011

Ustanove:
KBC "Sestre Milosrdnice"


Citiraj ovu publikaciju

Kaštelan, Željko; Pasini, Josip; Derežić, Danijel; Lukač, Josip; Kusić, Zvonko; Mrazovac, Danijel; Šošić, Hrvoje; Kaštelan, Maja
Immunocompetence in Non-seminomatosus Testicular Cancer Patients Before any Treatment and One Year After Completion of Therapy // Anticancer Research, 24 (2004), 5B; 3251-3255 (podatak o recenziji nije dostupan, članak, ostalo)
Kaštelan, Ž., Pasini, J., Derežić, D., Lukač, J., Kusić, Z., Mrazovac, D., Šošić, H. & Kaštelan, M. (2004) Immunocompetence in Non-seminomatosus Testicular Cancer Patients Before any Treatment and One Year After Completion of Therapy. Anticancer Research, 24 (5B), 3251-3255.
@article{article, year = {2004}, pages = {3251-3255}, keywords = {Non-seminomatous testicular cancer, immunocompetence}, journal = {Anticancer Research}, volume = {24}, number = {5B}, issn = {0250-7005}, title = {Immunocompetence in Non-seminomatosus Testicular Cancer Patients Before any Treatment and One Year After Completion of Therapy}, keyword = {Non-seminomatous testicular cancer, immunocompetence} }
@article{article, year = {2004}, pages = {3251-3255}, keywords = {Non-seminomatous testicular cancer, immunocompetence}, journal = {Anticancer Research}, volume = {24}, number = {5B}, issn = {0250-7005}, title = {Immunocompetence in Non-seminomatosus Testicular Cancer Patients Before any Treatment and One Year After Completion of Therapy}, keyword = {Non-seminomatous testicular cancer, immunocompetence} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font